Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127983321 | 12798332 | 1 | I | 20160922 | 20160930 | 20160930 | EXP | US-ASTRAZENECA-2016SF03131 | ASTRAZENECA | 62.00 | YR | F | Y | 88.00000 | KG | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127983321 | 12798332 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
| 127983321 | 12798332 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | ||||||||
| 127983321 | 12798332 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 20.0MG UNKNOWN | 0 | 20 | MG | TABLET | |||||||
| 127983321 | 12798332 | 4 | SS | BRILINTA | TICAGRELOR | 1 | Oral | Y | U | 0 | 90 | MG | TABLET | BID | |||||
| 127983321 | 12798332 | 5 | C | ADULT ASPIRIN | 2 | Unknown | UNKNOWN | 0 | |||||||||||
| 127983321 | 12798332 | 6 | C | ENBREL | ETANERCEPT | 1 | Unknown | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
| 127983321 | 12798332 | 7 | C | HYDROCHLORTHIAZIDE | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25.0MG UNKNOWN | 0 | 25 | MG | ||||||||
| 127983321 | 12798332 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 5.0MG UNKNOWN | 0 | 5 | MG | ||||||||
| 127983321 | 12798332 | 9 | C | MELOXICAM. | MELOXICAM | 1 | Unknown | 15.0MG UNKNOWN | 0 | 15 | MG | ||||||||
| 127983321 | 12798332 | 10 | C | VENLAFAXINE ER | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 150.0MG UNKNOWN | 0 | 150 | MG | ||||||||
| 127983321 | 12798332 | 11 | C | LETROZOLE. | LETROZOLE | 1 | Unknown | 2.5MG UNKNOWN | 0 | 2.5 | MG | ||||||||
| 127983321 | 12798332 | 12 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127983321 | 12798332 | 4 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127983321 | 12798332 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127983321 | 12798332 | Breast cancer female | |
| 127983321 | 12798332 | Cardiac failure congestive | |
| 127983321 | 12798332 | Chronic obstructive pulmonary disease | |
| 127983321 | 12798332 | Gastrointestinal haemorrhage | |
| 127983321 | 12798332 | Hepatitis C | |
| 127983321 | 12798332 | Hyperlipidaemia | |
| 127983321 | 12798332 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |